Original Research
Published on 24 Jul 2025
Dexmedetomidine reduces in-hospital mortality in aneurysmal subarachnoid hemorrhage patients by modulating three key genes and inflammatory pathways: insights from clinical and bioinformatics analyses
in Endovascular and Interventional Neurology
- 198 views